Health Cor Management, L.P. Merus N.V. Transaction History

Health Cor Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $2.86 Million - $4.45 Million	153,690 Added 128.93%	272,890 $5.47 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $104,011 - $217,620	7,440 Added 6.66%	119,200 $2.7 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $817,240 - $1.32 Million	40,862 Added 57.63%	111,760 $3.55 Million
Q3 2021 Nov 15, 2021	SELL	$16.48 - $27.23 $420,899 - $695,454	-25,540 Reduced 26.48%	70,898 $1.56 Million
Q2 2021 Aug 16, 2021	BUY	$20.0 - $25.48 $718,960 - $915,955	35,948 Added 59.43%	96,438 $2.03 Million
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $976,308 - $1.76 Million	60,490 New	60,490 $1.26 Million

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.